ASSETMARK, INC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1344551 CONCORD, CA

Position in LNTH

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$1,706,245

-$6,166,620 QoQ

Shares Held

22,495

-81.0% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ASSETMARK, INC holds $396,096,801 across 26 Drug Manufacturers - Specialty & Generic names. LNTH ranks #7 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	616,050	$365,305,329
2	ZTS	Zoetis Inc.	140,768	$16,640,185
3	TAK	Takeda Pharmaceutical Co Ltd	227,616	$4,215,448
4	NBIX	Neurocrine Biosciences Inc	17,277	$2,276,071
5	SUPN	Supernus Pharmaceuticals, Inc.	43,972	$2,272,912
6	TEVA	Teva Pharmaceutical Industries Ltd	63,314	$1,907,017
7	LNTH	Lantheus Holdings, Inc. This page	22,495	$1,706,245
8	AMPH	Amphastar Pharmaceuticals, Inc.	53,738	$1,052,727

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,706,245	22,495	-81.0%	Shares	Sole	2026-05-06
2025-12-31	$7,872,865	118,300	-0.2%	Shares	Sole	2026-01-23
2025-09-30	$6,078,018	118,503	+20.1%	Shares	Sole	2025-11-06
2025-06-30	$8,076,225	98,659	-2.7%	Shares	Sole	2025-08-04
2025-03-31	$9,899,665	101,431	+46.9%	Shares	Sole	2025-05-06
2024-12-31	$6,178,018	69,059	+10.0%	Shares	Sole	2025-02-06
2024-09-30	$6,892,519	62,802	+11.4%	Shares	Sole	2024-11-01
2024-06-30	$4,525,144	56,360	+517.8%	Shares	Sole	2024-08-13
2023-12-31	$565,626	9,123	+42.9%	Shares	Sole	2024-02-09
2023-09-30	$443,560	6,384	+45500.0%	Shares	Sole	2023-10-27
2023-03-31	$1,155	14	-82.5%	Shares	Defined	2023-05-05
2022-12-31	$4,076	80	0.0%	Shares	Defined	2023-02-10
2022-09-30	$5,626	80	—	Shares	Sole	2022-11-01
No filing history on record for this holder in this stock.